Table 1.

Clinical characteristics of PCa and BPH patients.

Characteristics	BPH	PCa	p-Value
Patients (n; %)	113 (51.6%)	106 (48.4%)
Age (years)	68.08 ± 8.99	69.97 ± 8.43	0.149*
PSA (ng/ml)	7.84 ± 2.55	7.48 ± 2.58	0.675*
F/T PSA	0.22 ± 0.24	0.18 ± 0.19	0.008*
AFU (U/L)	20.16 ± 6.17	18.21 ± 6.66	0.049*

p < 0.05 is considered as statistically significant.

PCa, prostate cancer; BPH, benign prostatic hyperplasia; PSA, prostate-specific antigen; F/T PSA, free/total prostate-specific antigen; AFU, alpha-l-fucosidase.

*p: Mann–Whitney U-test.